Trevi Therapeutics Inc (TRVI)
2.865
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 10:22
Trevi Therapeutics Price to Book Value: 3.735 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 3.728 |
| November 12, 2024 | 3.910 |
| November 11, 2024 | 4.002 |
| November 08, 2024 | 3.793 |
| November 07, 2024 | 3.780 |
| November 06, 2024 | 4.041 |
| November 05, 2024 | 3.937 |
| November 04, 2024 | 3.963 |
| November 01, 2024 | 3.924 |
| October 31, 2024 | 3.839 |
| October 30, 2024 | 3.916 |
| October 29, 2024 | 3.941 |
| October 28, 2024 | 4.069 |
| October 25, 2024 | 3.992 |
| October 24, 2024 | 3.979 |
| October 23, 2024 | 4.107 |
| October 22, 2024 | 4.133 |
| October 21, 2024 | 4.286 |
| October 18, 2024 | 3.992 |
| October 17, 2024 | 3.992 |
| October 16, 2024 | 4.095 |
| October 15, 2024 | 4.069 |
| October 14, 2024 | 4.069 |
| October 11, 2024 | 3.992 |
| October 10, 2024 | 3.839 |
| Date | Value |
|---|---|
| October 09, 2024 | 3.826 |
| October 08, 2024 | 4.031 |
| October 07, 2024 | 3.685 |
| October 04, 2024 | 3.864 |
| October 03, 2024 | 3.864 |
| October 02, 2024 | 4.082 |
| October 01, 2024 | 3.979 |
| September 30, 2024 | 4.274 |
| September 27, 2024 | 3.653 |
| September 26, 2024 | 3.456 |
| September 25, 2024 | 3.379 |
| September 24, 2024 | 3.477 |
| September 23, 2024 | 3.620 |
| September 20, 2024 | 3.774 |
| September 19, 2024 | 3.839 |
| September 18, 2024 | 3.741 |
| September 17, 2024 | 3.653 |
| September 16, 2024 | 3.850 |
| September 13, 2024 | 3.697 |
| September 12, 2024 | 3.620 |
| September 11, 2024 | 3.620 |
| September 10, 2024 | 3.456 |
| September 09, 2024 | 3.423 |
| September 06, 2024 | 3.236 |
| September 05, 2024 | 3.401 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5591
Minimum
Mar 30 2020
11.94
Maximum
Apr 25 2022
2.228
Average
1.786
Median
Aug 27 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9074 |
| Theriva Biologics Inc | 0.0516 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| Price | 2.865 |
| Earnings Yield | -15.36% |
| Market Cap | 220.22M |